Drugstore lobbyists' agenda raises Rx drug prices on consumers | NCPA: Proposed drug plan legislation could hurt Okla. consumers, raise costs | US pharmacy market more efficient than Europe's
April 26, 2016
FOLLOW PCMA ON TWITTER  Twitter
PCMA SmartBrief
News for the PBM Industry
SIGN UP ⋅   FORWARD ⋅   ARCHIVE
Featured Story
Drugstore lobbyists' agenda raises Rx drug prices on consumers
Lobbyists from drugstore trade associations are pushing the limits of prescription drug profits at the expense of consumers and their drug plans, according to National Center for Policy Analysis Senior Fellow Devon Herrick.
YouTube/NCPAIdeas (4/22) 
LinkedIn Twitter Facebook Google+ Email
Legislative & Regulatory News
US pharmacy market more efficient than Europe's
Regulatory barriers in Europe protect independent drugstores but inconvenience consumers and raise costs, writes Adam Fein, president of Pembroke Consulting.
Drug Channels (4/26) 
LinkedIn Twitter Facebook Google+ Email
N.Y. insurers expand HCV drug coverage
Seven health insurance carriers will expand hepatitis C drug coverage policies for New York residents with commercial plans, opening coverage to nearly all subscribers with the viral infection.
The Wall Street Journal (tiered subscription model) (4/25) 
LinkedIn Twitter Facebook Google+ Email
AbbVie's hepatitis C treatment wins expanded FDA approval
AbbVie has won approval from the FDA for the expanded use of Viekira Pak, a combination of ombitasvir, paritaprevir, ritonavir tablets and dasabuvir tablets, without ribavirin, as a treatment for chronic hepatitis C genotype 1b patients with compensated cirrhosis.
Drug Store News (4/25) 
LinkedIn Twitter Facebook Google+ Email
Insurers, AARP and Walmart advocate policies to cut drug prices
The Campaign for Sustainable Rx Pricing, which includes insurance plans, AARP and Walmart, is pushing for lower prescription drug prices through shorter exclusivity periods for biologics, increased FDA staff to cut the backlog of generic applications and greater cost transparency from drug manufacturers.
The Washington Post (tiered subscription model) (4/25) 
LinkedIn Twitter Facebook Google+ Email
Administration releases Medicaid managed care regulations
The federal government has released regulations governing the Medicaid managed care organizations that operate in 39 states and the District of Columbia, setting standards for provider networks, spending on medical care, fraud prevention, quality ratings and more.
ABC News/The Associated Press (4/25),  Kaiser Health News (4/26) 
LinkedIn Twitter Facebook Google+ Email
Chief justice calls inter partes review "bizarre"
The inter partes review process is "a bizarre way to decide a legal question," Supreme Court Chief Justice John Roberts said during oral arguments.
CQ.com (subscription required) (4/29) 
LinkedIn Twitter Facebook Google+ Email
Drug Industry Spotlight
Perrigo CEO to lead Valeant
Perrigo CEO Joseph Papa will take over as Valeant Pharmaceuticals CEO next month, and he said the company will make some changes.
Politico Pro (subscription required) (5/2) 
LinkedIn Twitter Facebook Google+ Email
  
  
You are too important to the bigger picture to just fall off the canvas.
Johnnie Dent,
writer
LinkedIn Twitter Facebook Google+ Email
  
  
Learn more about PCMA:
Upcoming PCMA Events | PCMA Newsroom
Become a PCMA Affiliate
About PCMA
PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 266 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D. PCMA is dedicated to enhancing the proven tools and techniques pioneered by PBMs that generate savings and access for consumers and payors.

Contact PCMA
Charles Cote
Vice President, Strategic Communications
Sign Up
SmartBrief offers 200+ newsletters
Subscriber Tools:
Contact Us:
Editor  -  Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2016 SmartBrief, Inc.®
Privacy policy |  Legal Information